Aquestive Therapeutics

company

About

Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems.

  • 101 - 250

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$20M
Industries
Pharmaceutical
Founded date
Jan 15, 2004
Number Of Employee
101 - 250
Operating Status
Active

Aquestive Therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. Aquestive is committed to addressing immediate CNS challenges by furthering its strong pipeline of products. As the undisputed leader in developing and delivering drugs via its proprietary technologies, the Company also collaborates with pharmaceutical partners to bring new molecules to market in differentiated and highly-marketable dosage forms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
Aquestive Therapeutics has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Sep 25, 2008 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 25, 2008 Debt Financing $20M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Aquestive Therapeutics is funded by 1 investors. Edward P. Bass Group are the most recent investors.
Investor Name Lead Investor Funding Round
Edward P. Bass Group Debt Financing